Christian Doppler Laboratory for Innovative Poultry Vaccines (IPOV), Austria.
Clinic for Poultry and Fish Medicine, Department for Farm Animals and Veterinary Public Health, University of Veterinary Medicine Vienna, Austria.
Vaccine. 2022 Aug 12;40(34):4986-4997. doi: 10.1016/j.vaccine.2022.07.001. Epub 2022 Jul 11.
Histomonosis (syn. blackhead disease) is caused by the protozoan parasite Histomonas meleagridis and can result in high mortality in turkey flocks, a situation driven by the limitation of prophylactic and therapeutic interventions. Multi-locus sequence typing confirmed the existence of two genotypes, with the vast majority of reported histomonosis outbreaks being caused by genotype 1 in contrast to only a few detections of genotype 2. For the first time, genotype 2 of H. meleagridis was successfully isolated from an outbreak of histomonosis in a flock of 5-week-old turkeys and a clonal culture was established. Using this culture, an experimental infection was performed in naïve turkeys. The animal trial reflected the observations from the field outbreak and coincided with a previously reported case of histomonosis caused by genotype 2, albeit no mortality was observed in the infected birds whereas 17.1% mortality was noticed in the field outbreak from appearance of disease until slaughter. Post mortem investigations demonstrated that lesions were restricted to the caeca in the field outbreak and the experimental trial. In parallel with the experimental reproduction of pathological changes, an oral vaccination of day-old turkeys with a monoxenic genotype 1 vaccine was carried out to determine efficacy against a genotype 2 challenge. Successful vaccine uptake was characterized by the presence of the vaccine in the caeca determined by qPCR and immunohistochemistry (IHC). Excretion of the vaccine strain was confirmed prior challenge, with the majority of birds developing antibodies. The new monoxenic vaccine was able to minimize lesions in the caeca demonstrating heterologous protection. No parasites were detected in the liver by IHC in any of the vaccinated birds, compared to non-vaccinated animals. However, in 6 out of 17 birds of the vaccinated group a positive signal was obtained by real time PCR from liver samples with 2 positives being typeable by conventional PCR as genotype 2. Overall, H. meleagridis genotype 2 infection was successfully reproduced. Experimental vaccination with a genetically distantly related genotype 1 was able to reduce lesions, supporting protection by a recently developed vaccine candidate as an efficacious prophylactic strategy.
组织滴虫病(又称黑头病)是由原生动物寄生虫组织滴虫引起的,可导致火鸡群死亡率很高,这种情况是由于预防和治疗干预措施的局限性造成的。多位点序列分型证实存在两种基因型,与报道的绝大多数组织滴虫病暴发由基因型 1 引起相比,只有少数检测到基因型 2。这是首次成功地从一群 5 周龄火鸡的组织滴虫病暴发中分离出组织滴虫的基因型 2,并建立了克隆培养。利用该培养物,对天真火鸡进行了实验感染。动物试验反映了现场暴发的观察结果,并与之前报道的由基因型 2 引起的组织滴虫病病例相吻合,尽管感染鸟类没有死亡,但在现场暴发中从发病到屠宰观察到 17.1%的死亡率。尸检调查表明,病变仅局限于现场暴发和实验试验中的盲肠。在实验性重现病理变化的同时,对 1 日龄火鸡进行了单性繁殖的基因型 1 疫苗口服接种,以确定对基因型 2 挑战的效力。成功的疫苗接种通过 qPCR 和免疫组织化学(IHC)确定疫苗在盲肠中的存在来表征。在挑战前确认了疫苗株的排出,大多数鸟类都产生了抗体。新的单性繁殖疫苗能够最大限度地减少盲肠中的病变,证明具有异源保护作用。在任何接种鸟类的肝脏中均未通过 IHC 检测到寄生虫,而非接种动物则未检测到寄生虫。然而,在接种组的 17 只鸟中的 6 只,从肝脏样本中通过实时 PCR 获得了阳性信号,其中 2 个阳性信号可通过常规 PCR 鉴定为基因型 2。总的来说,成功地再现了组织滴虫的基因型 2 感染。用遗传上亲缘关系较远的基因型 1 进行实验性接种能够减少病变,支持最近开发的疫苗候选物作为有效的预防性策略的保护作用。